CClinicalTrials.gg
CompletedNCT02209103Updated Nov 20, 2015

The Sleep Improving Effects of Orange Phenolics

An interventional study of Lozenge containing citrus flavonoid and Lozenge containing citrus flavonoid formulation in Polyphenols, Sleep and Fatigue, sponsored by Maastricht University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2015-11-20.

Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
77
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study aims to determine whether a citrus flavonoid or a citrus flavonoid formulation can improve objective sleep duration and/or quality, and/or improve perceived sleep quality and feelings of rest.

Participants will complete a total of 9 test nights, which consist of sleeping with the sleep monitoring system after ingestion of the test product or a placebo, and filling out sleep-related questionnaires.

The study has a crossover design, meaning that all participants receive all three interventions (citrus flavonoid, citrus flavonoid formulation, placebo) three times, in a randomized order.

02

Conditions studied

  • Polyphenols
  • Sleep
  • Fatigue

Browse trials for

Keywords

  • Polyphenols
  • Orange
  • Sleep
  • Fatigue
03

In context

Fatigue

1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.

This study's enrollment of 77 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 835 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-75
  • Non-smoking
  • Healthy
  • Lightly disturbed sleep for at least six months, on a regular basis

Exclusion criteria

Exclusion Criteria:

  • Severe sleep disorders (sleep apnea, restless legs syndrome)
  • An apparent cause for the sleep disorders (pain, etc.)
  • Clinically significant abnormal liver functioning
  • Clinically significant abnormal serum creatinine
  • BMI lower than 18 or higher than 30 kg/m2
  • Use of concomitant medications or supplements
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
77 participants (actual)

Study arms

  • Experimental
    Citrus flavonoid

    Citrus flavonoid

    Dietary Supplement: Lozenge containing citrus flavonoid

  • Experimental
    Citrus flavonoid formulation

    Citrus flavonoid formulation

    Dietary Supplement: Lozenge containing citrus flavonoid formulation

  • Placebo comparator
    Placebo

    Placebo

    Dietary Supplement: Identical looking placebo

Interventions

  • Dietary supplementLozenge containing citrus flavonoid
  • Dietary supplementLozenge containing citrus flavonoid formulation
  • Dietary supplementIdentical looking placebo
06

What researchers measure

Primary outcomes

  1. Sleep quality as assessed objectively by means of a portable sleep monitoring system (ZEO)

    • The primary endpoint for this study is the determination of sleep quality, as assessed objectively with the portable sleep monitoring system ZEO, which is based on EEG/EMG (electromyography) coupled with an automatic sleep phase classifier. Sleep stages are classified as deep sleep, light sleep, REM (rapid eye movement) sleep or awake. The sleep patterns of the participants after ingestion of the two different test products will be compared to each other and to placebo.

    Time frame: 9 test nights (up to 9 days)

Secondary outcomes

  1. Subjective sleep quality ratings and fitness, tiredness and cognitive ratings, obtained from questionnaires

    Leeds Sleep Evaluation Questionnaire

    Time frame: up to 9 days. Questionnaires are filled out the morning after every test night

07

Study locations

1 site
  • Maastricht University Medical Center (MUMC)
    Maastricht, 6229, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 20, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02209103
Lead sponsor
Maastricht University Medical Center
Responsible party
Sponsor
First posted
Aug 5, 2014
Start date
Mar 2014
Primary completion
Sep 2014
Completion
Sep 2014
Last update
Nov 20, 2015

Study contacts

Chris Van der Grinten
principal investigator · Department: lung diseases MUMC

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion